Found 262 matching trials
Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration N/A In this study, investigators utilize a radiopathomics integrated Artificial...
Show More Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System PHASE2 To seek the efficacy signals of trastuzumab in combination with chemotherap...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. PHASE2 This is a multicenter, two-arm, exploratory clinical study designed to eval...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Tumor Markers for Efficacy of Dual-Target Therapy in HER2+ Breast Cancer NA This is a prospective, randomized study to compare the efficacy of TP (Taxa...
Show More Learn More & Join Trial
NeoPHOEBE: Neoadjuvant Trastuzumab + BKM120 in Combination With Weekly Paclitaxel in HER2-positive Primary Breast Cancer PHASE2 This randomized, parallel cohort, two stage, double-blind, placebo-controll...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer PHASE2 Phase II trial to study the effectiveness of combination chemotherapy with ...
Show More Location
Eastern Cooperative Oncology Group
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis PHASE2 A phase II, open-label, multicenter, randomized controlled trial exploring ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer N/A Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX PHASE2 This is an open-label, multicentre, prospective phase II trial designed to ...
Show More Location
Asan Medical Center
Learn More & Join Trial